Filing Details
- Accession Number:
- 0001179110-16-019895
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-23 17:44:00
- Reporting Period:
- 2016-02-19
- Filing Date:
- 2016-02-23
- Accepted Time:
- 2016-02-23 17:44:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1636628 | S. Deepak Nath | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2016-02-19 | 16,601 | $0.00 | 51,542 | No | 4 | A | Direct | |
Common Shares Without Par Value | Disposition | 2016-02-21 | 819 | $38.53 | 50,723 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2016-02-22 | 19 | $39.09 | 50,704 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2016-02-22 | 300 | $39.10 | 50,404 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Acquisiton | 2016-02-19 | 145,547 | $0.00 | 145,547 | $38.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
145,547 | 2017-02-19 | 2026-02-18 | No | 4 | A | Direct |
Footnotes
- These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 48,516 on 02/19/2017, 48,515 on 02/19/2018, and 48,516 on 02/19/2019.